Landfar(SZ:000504) Zheng Quan Ri Bao Wang·2025-10-26 12:44Core Insights - *ST Bio reported a revenue of 83.4385 million yuan for the first three quarters of 2025, representing a year-on-year decline of 9.72% [1] Business Developments - The company has implemented several major operational initiatives to optimize its business structure, cultivate new profit growth points, and mitigate operational risks during the first three quarters of the year [1] - In June 2025, *ST Bio initiated the sale of its 52% stake in Nanhua Peace Hospital Management (Hunan) Co., Ltd., with a listing price of 19.9919 million yuan to focus resources on core business [1] - The company acquired a 43.05% stake in Loudi Jinhong New Materials Co., Ltd. for 48.6249 million yuan and simultaneously increased its capital by 30 million yuan to extend its main business track [1] - In August 2025, *ST Bio disclosed plans to acquire a 51% stake in Hunan Huize Biomedical Technology Co., Ltd. in cash, which is expected to constitute a major asset restructuring [1]